Accessibility: Skip TopNav
Qualigen Therapeutics, Inc.
F3-8-60 inhibits RAS RAF interaction and blocks RAS Signaling
Format
PNG
Source
Qualigen Therapeutics, Inc.
Téléchargements
Original
Grand
Moyen
Petit